Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IR (index of reactivity)-house dust mite sublingual immunotherapy liquid formulation for allergic rhinoconjunctivitis: Systematic review and meta-analysis of randomized and nonrandomized studies.
Di Bona D, Carlucci P, Spataro F, Paoletti G, Cognet-Sicé J, Scurati S, Canonica GW. Di Bona D, et al. Among authors: scurati s. J Allergy Clin Immunol Glob. 2024 Jan 9;3(2):100208. doi: 10.1016/j.jacig.2024.100208. eCollection 2024 May. J Allergy Clin Immunol Glob. 2024. PMID: 38328804 Free PMC article.
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort.
Devillier P, Molimard M, Bergmann JF, Delaisi B, Gouverneur A, Vadel J, Collin C, Girard L, Scurati S, Demoly P. Devillier P, et al. Among authors: scurati s. Expert Rev Clin Immunol. 2024 Apr;20(4):405-412. doi: 10.1080/1744666X.2023.2294040. Epub 2023 Dec 19. Expert Rev Clin Immunol. 2024. PMID: 38112340
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study).
Demoly P, Molimard M, Bergmann JF, Delaisi B, Gouverneur A, Vadel J, Collin C, Girard L, Scurati S, Devillier P. Demoly P, et al. Among authors: scurati s. Lancet Reg Health Eur. 2024 Apr 26;41:100915. doi: 10.1016/j.lanepe.2024.100915. eCollection 2024 Jun. Lancet Reg Health Eur. 2024. PMID: 38707866 Free PMC article.
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model.
Incorvaia C, Al-Ahmad M, Ansotegui IJ, Arasi S, Bachert C, Bos C, Bousquet J, Bozek A, Caimmi D, Calderón MA, Casale T, Custovic A, De Blay F, Demoly P, Devillier P, Didier A, Fiocchi A, Fox AT, Gevaert P, Gomez M, Heffler E, Ilina N, Irani C, Jutel M, Karagiannis E, Klimek L, Kuna P, O'Hehir R, Kurbacheva O, Matricardi PM, Morais-Almeida M, Mosges R, Novak N, Okamoto Y, Panzner P, Papadopoulos NG, Park HS, Passalacqua G, Pawankar R, Pfaar O, Schmid-Grendelmeier P, Scurati S, Tortajada-Girbés M, Vidal C, Virchow JC, Wahn U, Worm M, Zieglmayer P, Canonica GW. Incorvaia C, et al. Among authors: scurati s. Allergy. 2021 Apr;76(4):1041-1052. doi: 10.1111/all.14575. Epub 2020 Oct 19. Allergy. 2021. PMID: 32869882 Review.
Lack of sterol regulatory element binding factor-1c imposes glial Fatty Acid utilization leading to peripheral neuropathy.
Cermenati G, Audano M, Giatti S, Carozzi V, Porretta-Serapiglia C, Pettinato E, Ferri C, D'Antonio M, De Fabiani E, Crestani M, Scurati S, Saez E, Azcoitia I, Cavaletti G, Garcia-Segura LM, Melcangi RC, Caruso D, Mitro N. Cermenati G, et al. Among authors: scurati s. Cell Metab. 2015 Apr 7;21(4):571-83. doi: 10.1016/j.cmet.2015.02.016. Epub 2015 Mar 26. Cell Metab. 2015. PMID: 25817536 Free article.
53 results